RH Nanopharmaceuticals Company

RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases. Inflammation is at the heart of conditions such as osteoarthritis,type 2 diabetes, acute and chronic pain, traumatic brain injury, Alzheimer’s Disease, Dry Eye Disease (DED), inflammatory bowel disorders such as ulcerative colitis and Crohn’s Disease. RH NANO has reformulated a medication called salsalate which has been used for arthritis and diabetes for over 100 years. RH NANO is proud to be the first pharmaceutical company to successfully produce a nanoparticle of salsalate to be used in all the above mentioned inflammatory disorders. Salsalate in both standard and nanoparticle size is the safest anti-inflammatory/analgesic medicine known to physicians.
Technology: NeuroTech
Industry: P4 Medicine
Headquarters: Monmouth Beach, New Jersey, United States
Zip: 11-50
Founded Date: 2017-01-01
Employees Number: 11-50
Acquisitions Number: 1
Investors Number: 1
Total Funding: $1M to $10M
Estimated Revenue: $1M to $10M
Last Funding Date: Grant
Last Funding Type: info@rhnanopharma.com

Visit Website
https://twitter.com/RHNanopharma
https://www.crunchbase.com/organization/rh-nanopharma
Register and Claim Ownership